Proinflammatory response and IL-12 expression in HIV-1 infection

Journal of Leukocyte Biology

Volumn 68, Issue 3, 2000, Pages 383-390

  Ma, X ^a   Montaner, L J ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

Interferon; Transforming growth factor ; Tumor necrosis factor

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD4 ANTIGEN; COMPLEMENT RECEPTOR; CYTOKINE; FC RECEPTOR; GAMMA INTERFERON; GLYCOPROTEIN GP 39; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 10; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; PROSTAGLANDIN E2; TRANSCRIPTION FACTOR; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CELLULAR IMMUNITY; GENE EXPRESSION REGULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; REVIEW; TRANSCRIPTION REGULATION; VIRUS INFECTION;

ANIMALS; GENE EXPRESSION REGULATION; HIV INFECTIONS; HIV-1; HUMANS; INFLAMMATION; INTERLEUKIN-12;

ALPHAVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0033637535     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (116)

1. Interleukin-12: A cytokine at the interface of inflammation and immunity
2. Type 1 cytokine production and low prevalence of viral isolation correlate with long-term nonprogression in HIV infection
3. Type 1 and type 2 cytokine profiles in children exposed to or infected with vertically transmitted human immunodeficiency virus
4. Cytokine profiles in HIV type 1 disease and protection
5. Cytokines and cytokine therapies in HIV infection
6. Impaired interleukin 12 production in human immunodeficiency virus-infected patients
7. Dysregulation of interleukin 8, interleukin 10, and interleukin 12 release by alveolar macrophages from HIV type 1-infected subjects
8. Dysregulated production of interleukin-10 (IL-10) and IL-12 by peripheral blood lymphocytes from human immunodeficiency virus-infected individuals is associated with altered proliferative responses to recall antigens
9. Molecular analysis of decreased interleukin-12 production in persons infected with human immunodeficiency virus
10. Altered cytokine production and accessory cell function after HIV-1 infection
11. Role of IL-12 in peripheral blood mononuclear cell responses to fungi in persons with and without HIV infection
12. Interleukin-12 (IL-12) production in whole blood cultures from human immunodeficiency virus-infected individuals studied in relation to IL-10 and prostaglandin E2 production
13. Human immunodeficiency virus gp120 inhibits interleukin-12 secretion by human monocytes: An indirect interleukin-10-mediated effect
14. Priming with IL-4 and IL-13 during HIV-1 infection restores in vitro IL-12 production by mononuclear cells of HIV-infected patients
15. Priming with IFN-gamma restores deficient IL-12 production by peripheral blood mononuclear cells from HIV-seropositive donors
16. HIV type 1 Tat protein inhibits interleukin 12 production by human peripheral blood mononuclear cells
17. Enhanced interleukin-10 production in response to Mycobacterium avium products in mononuclear cells from patients with human immunodeficiency virus infection
18. Impaired cytokine production by neutrophils isolated from patients with AIDS
19. CD40 ligand and IFN-gamma synergistically restore IL-12 production in HIV-infected patients
20. A decreased production of IL12 in vitro is associated with isolation of cytopathic HIV-1 strains in HIV-1-infected patients
21. Protein levels of interleukin-12 p70 holomer, its p40 chain and interferon-gamma during advancing HIV infection
22. The effects of CD40 ligation on peripheral blood mononuclear cell interleukin-12 and interleukin-15 production and on monocyte CD14 surface antigen expression in human immunodeficiency virus-positive patients
23. Levels of nitric oxide, gamma interferon and interleukin-12 in AIDS patients with toxoplasmic encephalitis
24. Normal immune function of monocyte-derived dendritic cells from HIV-infected individuals: Implications for immunotherapy
25. Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection
26. The interleukin-12-mediated pathway of immune events is dysfunctional in human immunodeficiency virus-infected individuals
27. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes
28. The two faces of interleukin 12: A pro-inflammatory cytokine and a key immunoregulatory molecule produced by antigen-presenting cells
29. Proinflammatory and immunoregulatory functions of interleukin-12
30. Inhibition of interferon gamma induced interleukin 12 production: A potential mechanism for the anti-inflammatory activities of tumor necrosis factor
31. CD40/CD40 ligand interactions are required for T cell-dependent production of interleukin-12 by mouse macrophages
32. Induction of IL-12 p40 messenger RNA expression and IL-12 production of macrophages via CD40-CD40 ligand interaction
33. Antigen-driven but not lipopolysaccharide-driven IL-12 production in macrophages requires triggering of CD40
34. Differential effects of LPS and CD40 ligand stimulations on the induction of IL-12 production by dendritic cells and macrophages
35. Antitumor effect of CD40 ligand: Elicitation of local and systemic antitumor responses by IL-12 and B7
36. Sensitized lymphocytes and CD40 ligation augment interleukin-12 production by human dendritic cells in response to Toxoplasma gondii
37. CD40-CD40 ligand interaction is central to cell-mediated immunity against Toxoplasma gondii: Patients with hyper IgM syndrome have a defective type 1 immune response that can be restored by soluble CD40 ligand trimer
38. CD40-CD154 interaction and IFN-gamma are required for IL-12 but not prostaglandin E2 secretion by microglia during antigen presentation to Th1 cells
39. Th1 cells induce and Th2 inhibit antigen-dependent IL-12 secretion by dendritic cells
40. Interleukin-12 production by dendritic cells. The role of CD40-CD40L interactions in Th1 T-cell responses
41. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion
42. The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells
43. Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10
44. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-gamma)
45. TGF-beta and fibrosis
46. Reversal of tumor-induced immunosuppression: A new approach to cancer therapy
47. IFN-beta differentially regulates CD40-induced cytokine secretion by human dendritic cells
48. IFN-beta interferes with the differentiation of dendritic cells from peripheral blood mononuclear cells: Selective inhibition of CD40-dependent interleukin-12 secretion
49. Type I IFNs inhibit human dendritic cell IL-12 production and Th1 cell development
50. Interferon-alpha/beta inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection
51. Role of interleukin-10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus
52. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: Analysis of underlying mechanisms and modulation with therapy
53. Cytokine patterns in adults with AIDS
54. Increased levels of transforming growth factor-beta in HIV-associated nephropathy
55. Mechanism of suppression of cell-mediated immunity by measles virus
56. Inhibition of HIV-1 infection in vitro by monoclonal antibodies to the complement receptor type 3 (CR3): An accessory role for CR3 during virus entry?
57. Role of complement in HIV infection
58. Circulating immune complexes in tuberculosis - An indicator of activity
59. Immune complexes and malignancy
60. Selective suppression of interleukin-12 induction after macrophage receptor ligation
61. Regulation of interleukin-12 by complement receptor 3 signaling
62. Immune complexes are potent inhibitors of interleukin-12 secretion by human monocytes
63. Signal transduction via Fc gamma R and Mac-1 alpha-chain in monocytes and polymorphonuclear leucocytes
64. CR3 (Mac-1, alpha M beta 2, CD11b/CD18) and Fc gamma RIII cooperate in generation of a neutrophil respiratory burst: Requirement for Fc gamma RIII and tyrosine phosphorylation
65. Granulocyte activation via a binding site near the C-terminal region of complement receptor type 3 alpha-chain (CD11b) potentially involved in intramembrane complex formation with glycosylphosphatidylinositol-anchored Fc gamma RIIIB (CD16) molecules
66. Effect of iC3b binding to immune complexes upon the phagocytic response of human neutrophils: Synergistic functions between Fc gamma R and CR3
67. 2+ in Fc gamma R(CD16)-induced transcription and expression of lymphokine genes
68. Cross-linking of both Fc gamma RI and Fc gamma RII induces secretion of tumor necrosis factor by human monocytes, requiring high affinity Fc-Fc gamma R interactions. Functional activation of Fc gamma RII by treatment with proteases or neuraminidase
69. Cytokine induction in human mononuclear cells stimulated by IgG-coated culture surfaces and by IgG for infusion
70. Regulation of tumor necrosis factor (TNF) release by murine peritoneal nnacrophages: Role of cell stimulation and specific phagocytic plasma membrane receptors
71. Monokines released during short-term Fc gamma receptor phagocytosis upregulate polymorphonuclear leukocytes and monocyte-phagocytic function
72. Phospholipase D activation in human natural killer cells through the Kp43 and CD16 surface antigens takes place by different mechanisms. Involvement of the phospholipase D pathway in tumor necrosis factor alpha synthesis
73. Cross-linking of monocyte plasma membrane Fc alpha, Fc gamma or mannose receptors induces TNF production
74. Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects
75. Fc alpha receptors mediate release of tumour necrosis factor-alpha and interleukin-6 by human monocytes following receptor aggregation
76. Fc receptor biology
77. HIV infection suppresses type 1 lymphokine and IL-12 responses to Toxoplasma gondii but fails to inhibit the synthesis of other parasite-induced monokines
78. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
79. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection
80. IL-2 and IL-12 act in synergy to overcome antigen-specific T cell unresponsiveness in mycobacterial disease
81. The induction of a protective response in Leishmania major-infected BALB/c mice with anti-CD40 mAb
82. Regulation of interleukin 12 p40 expression through an NF-kappa B half-site
83. Identification and characterization of a novel Ets-2-related nuclear complex implicated in the activation of the human interleukin-12 p40 gene promoter
84. Multiple control elements mediate activation of the murine and human interleukin 12 p40 promoters: Evidence of functional synergy between C/EBP and Rel proteins
85. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1
86. Impaired production of lymphokines and immune (gamma) interferon in the acquired immunodeficieney syndrome
87. IL-13 and IFN-gamma secretion by activated T cells in HIV-1 infection associated with viral suppression and a lack of disease progression
88. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction
89. TNF, immunity and inflammatory disease: Lessons of the past decade
90. TNF, apoptosis and autoimmunity: A common thread?
91. Involvement of TNF-alpha secreting macrophages in lethal forms of human graft-versus-host disease
92. Anti-tumor necrosis factor-alpha monoclonal antibody therapy for rheumatoid arthritis
93. Mucosal inflammatory cytokine production by intestinal biopsies in patients with ulcerative colitis and Crohn's disease
94. Anticytokine approaches to the treatment of anorexia and cachexia
95. Enhanced production of tumor necrosis factor-alpha and interleukin-6 due to prolonged response to lipopolysaccharide in human macrophages infected in vitro with human immunodeficiency virus type 1
96. Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin- 1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity
97. TNF-alpha production by U937 promonocytes is enhanced by factors released from HIV-infected T4 lymphocytes: TNF-alpha is one of the mediators causing lysis of HIV-infected T4 cells
98. The effects of the HIV-1 envelope protein gp120 on the production of nitric oxide and proinflammatory cytokines in mixed glial cell cultures
99. Inflammatory cytokine expression is correlated with the level of human immunodeficiency virus (HIV) transcripts in HIV-infected placental trophoblastic cells
100. HIV-1 exposed dendritic cells show increased pro-inflammatory cytokine production but reduced IL-1ra following lipopolysaccharide stimulation
101. Characterization of tumor necrosis factor-deficient mice
102. Inhibition of IL-12 production in human monocyte-derived macrophages by TNF
103. Induction of IFN-alpha by HIV-1 in monocyte-enriched PBMC requires gp120-CD4 interaction but not virus replication
104. + blood dendritic cells are potent producers of IFN-alpha in response to in vitro HIV-1 infection
105. Interferon alpha and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS
106. Persistent alterations in T-cell repertoire, cytokine and chemokine receptor gene expression after 1 year of highly active antiretroviral therapy
107. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71)
108. Kaposi's sarcoma: Its 'oncogenes' and growth factors
109. Macrophage- and astrocyte-derived transforming growth factor beta as a mediator of central nervous system dysfunction in acquired immune deficiency syndrome
110. Transforming growth factor-beta and suppression of humoral immune responses in HIV infection
111. Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV
112. Increased PGE2 production mediates the in vitro inhibitory effect of the human immunodeficiency virus P24 immunosuppressive heptapeptide Ch7
113. Expression patterns of Fc gamma receptors, HLA-DR and selected adhesion molecules on monocytes from normal and HIV-infected individuals
114. Phenotypic changes of monocytes induced by HIV-1 gp120 molecule and its fragments
115. Diminished expression of cell-surface complement regulatory proteins in HIV-infected children and with HIV infection of peripheral blood mononuclear cells in vitro
116. + lymphocytes from human immunodeficiency virus-1 infected individuals